Abstract:Our findings provide a novel and effective combination strategy for increasing potent anthelmintic agent avermectin B1a production by enhancing supplies of both acyl‐CoA starter and extender units. We achieved significant increase of B1a titer in Streptomyces avermitilis WT and industrial strains by heterologous expression of assembled loading module‐extension module 7‐TE domain of meilingmycin polyketide synthase, inhibition of key nodes in FA synthesis and TCA cycle pathways using CRISPRi, and co‐overexpression of β‐oxidation pathway genes fadD and fadAB for increasing levels of 2‐methylbutyryl‐CoA, malonyl‐CoA, and methylmalonyl‐CoA precursors. Such precursor supply strategies can be readily adapted for overproduction of other polyketides. Avermectins (AVEs), a family of macrocyclic polyketides produced by Streptomyces avermitilis, have eight components, among which B1a is noted for its strong insecticidal activity. Biosynthesis of AVE "a" components requires 2‐methylbutyryl‐CoA (MBCoA) as starter unit, and malonyl‐CoA (MalCoA) and methylmalonyl‐CoA (MMCoA) as extender units. We describe here a novel strategy for increasing B1a production by enhancing acyl‐CoA precursor supply. First, we engineered meilingmycin (MEI) polyketide synthase (PKS) for increasing MBCoA precursor supply. The loading module (using acetyl‐CoA as substrate), extension module 7 (using MMCoA as substrate) and TE domain of MEI PKS were assembled to produce 2‐methylbutyrate, providing the starter unit for B1a production. Heterologous expression of the newly designed PKS (termed Mei‐PKS) in S. avermitilis wild‐type (WT) strain increased MBCoA level, leading to B1a titer 262.2 μg/mL – 4.36‐fold higher than WT value (48.9 μg/mL). Next, we separately inhibited three key nodes in essential pathways using CRISPRi to increase MalCoA and MMCoA levels in WT. The resulting strains all showed increased B1a titer. Combined inhibition of these key nodes in Mei‐PKS expression strain increased B1a titer to 341.9 μg/mL. Overexpression of fatty acid β‐oxidation pathway genes in the strain further increased B1a titer to 452.8 μg/mL – 8.25‐fold higher than WT value. Finally, we applied our precursor supply strategies to high‐yield industrial strain A229. The strategies, in combination, led to B1a titer 8836.4 μg/mL – 37.8% higher than parental A229 value. These findings provide an effective combination strategy for increasing AVE B1a production in WT and industrial S. avermitilis strains, and our precursor supply strategies can be readily adapted for overproduction of other polyketides.

Effects of amino acid precursor on the avermectin biosythesis

Effects of Amino Acids on the Biosynthesis of Validamycin A in the Fermentation of Streptomyces Hygroscopicus 5008

[Comparative metabolomics analysis of metabolic pathways in the high-yielding mutant strain of avilamycin]

Effect of Inoculation Methods on Avermectin Fermentation by Streptomyces Avermilitis

Direct Proteomic Mapping of Streptomyces Avermitilis Wild and Industrial Strain and Insights into Avermectin Production

Correlation Between Organic Acids Accumulation and Biosynthesis of Avermectin

Overexpression of the ABC Transporter AvtAB Increases Avermectin Production in Streptomyces Avermitilis.

Avermectin B1a production in Streptomyces avermitilis is enhanced by engineering aveC and precursor supply genes

Enhancement of acyl‐CoA precursor supply for increased avermectin B1a production by engineering meilingmycin polyketide synthase and key primary metabolic pathway genes

[Effect of Nitrogen on Avermectins Biosynthesis and Its Fermentation Optimization Based on Carbon-Dioxide Evolution Rate].

Effect of Mycelial Morphology on Bioreactor Performance and Avermectin Production of Streptomyces Avermitilis in Submerged Cultivations

Significance of Heavy-Ion Beam Irradiation-Induced Avermectin B1a Production by Engineered Streptomyces Avermitilis.

Effect of Valine on the Biosynthesis of Biotechspiramycin in Chemically Defined Culture

Effect of valine,isoleucine and leucine on the biosythesis of biotechspiramycin

Research progress of avermectin: A minireview based on the structural derivatization of avermectin

Avilamycin production enhancement by mutagenesis and fermentation optimization in Streptomyces viridochromogenes

Positive Regulation of Avermectin Biosynthesis by AveR in Streptomyces Avermitilis

Effects Analysis of Adding Branched Amino Acids on the Biosynthesis of Ansamitocins by Actinosynnema mirum

Synthetic Biology of Avermectin for Production Improvement and Structure Diversification

Raising the avermectins production in Streptomyces avermitilis by utilizing nanosecond pulsed electric fields (nsPEFs)

Toxic effects of avermectin on liver function, gut microbiota, and colon barrier in the rat model